the
health strategy
institute
the knowledge portal of “the health strategist — institute”
for in-person health strategy
and digital health strategy
Joaquim Cardoso MSc
Chief Researcher and Strategy Officer (CRSO)
for “the health strategist ” — research unit
Chief Editor for“the health strategist” — knowledge portal
Senior Advisor — for “the health strategist” — advisory consulting
SOURCE: The Telegraph
Inoculation should save thousands of lives each year and help end deadly outbreaks across the continent
ByBen Farmer14 July 2023 • 2:09pm
A “game-changer” UK-funded vaccine to wipe out deadly meningitis infections across a swathe of Africa has been judged safe and effective by the World Health Organization.
The new, lower-cost MenFive vaccine should save thousands of lives each year and help end deadly outbreaks of meningococcal meningitis in Africa, developers said.
MenFive is the first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis on the continent, which can kill children in a matter of hours.
It should provide better and longer lasting protection compared to previous versions, and be more affordable for use in poorer countries.
The vaccine is the result of a 13-year-collaboration between India’s Serum Institute and the global health organisation PATH, with UK funding.
TO CONTINUE READING:
